While there is along way to go to restore any shred of credibility, I will reiterate some positives to come out of Q4
Partners up from 215 to 225, and no partners lost
GP% up to 69% Q4 and expected to be >70% in FY25
Expect cash costs to better match payments, so the 1.3 quarters of remaining funds is misleading - probably more like 4-quarters, still tight
Looking at alternate sources of funding to get through to breakeven (rather than another dilutive raise).
Looking to update the market monthly?/regularly - can't ask for much more.
I would also point out Directors took $500k in stock at the recent 5cps placement (mostly PP - $379k), and $1.25m in the 14cps placement.
I am as angry as the next shareholder about what has gone on here, down >$25k and I bought in at 14cps, but I see positive shoots, could be BS but surely an entire board and management are not in on the charade.....
- Forums
- ASX - By Stock
- DUB
- Ann: Dubber Q4 FY24 Results Webinar
Ann: Dubber Q4 FY24 Results Webinar, page-17
Featured News
Add DUB (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.9¢ |
Change
0.001(5.56%) |
Mkt cap ! $26.35M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.9¢ | $98.49K | 5.183M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 908648 | 1.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 40493 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 908648 | 0.018 |
12 | 1871858 | 0.017 |
24 | 5854917 | 0.016 |
14 | 2102002 | 0.015 |
7 | 2298972 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 40493 | 1 |
0.020 | 1466005 | 6 |
0.021 | 1172552 | 3 |
0.022 | 979634 | 2 |
0.023 | 150000 | 2 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
DUB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online